British artificial intelligence (AI) firm Sensyne Health has entered a formal research agreement with the UK Medicines and Healthcare products Regulatory Agency (MHRA) to help develop methods to validate software algorithms used in digital health.
The firm announced the collaboration in its annual report for the year ending April 2019, which was published this week. Sensyne also revealed it has stuck a deal with a Fortune 200 company....
Tags : cardiovascular disease, clinical development , Life Sciences Industrial , clinical AI , aid healthcare,
comments (0)